Capital Research Global Investors 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-10 12:21 pm Sale |
2021-08-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 3,842,491 4.800% |
-4,181,639 (-52.11%) |
Filing |
| 2021-02-10 12:30 pm Purchase |
2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 8,024,130 10.200% |
287,382 (+3.71%) |
Filing |
| 2021-02-10 12:26 pm Purchase |
2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 7,736,748 9.800% |
7,736,748 (New Position) |
Filing |